At the conclusion of this activity, participants should be able to:

1. Describe new advances in the pharmacotherapy and psychotherapy of addictive disorders.
2. Discuss the epidemiology of substance use disorders and their co-occurrence with other psychiatric disorders and review current recommended approaches for concurrent treatment of substance use disorders and other mental health disorders.
3. Describe the role of genetics in the risk for developing alcohol and other drug use disorders.
4. Identify the major neurobiological pathways involved in addictive disorders.
5. Identify the molecular mechanisms that are altered following drug and alcohol use.
6. Review the literature on screening and brief intervention effectiveness and teach this technique so it is applied.
7. Review current treatment guidelines and how to utilize them in clinical practice.
8. Describe special considerations for addiction diagnosis and treatment for women, underrepresented racial and ethnic minorities, youth, older adults, hospitalized patients, and patients with comorbid health conditions.